Literature DB >> 16801828

Blood glucose before and after ECT treatments in Type 2 diabetic patients.

Keith G Rasmussen1, Debra A Ryan, Paul S Mueller.   

Abstract

Electroconvulsive therapy (ECT) is often performed for patients with psychiatric disorders who also have diabetes mellitus. Some research has suggested that the course of ECT treatments does not have a consistent effect on blood glucose, but little data exist to inform the clinician about the effects of individual ECT treatments on blood glucose. In this study, 18 patients with type 2 diabetes mellitus were treated with ECT for severe depressive illness. For each patient, a fingerstick blood glucose was routinely obtained before and approximately 20 minutes after each ECT treatment. We found a mean rise of blood glucose after each treatment of approximately 9%, similar to the mean rise of blood glucose among nondiabetic patients undergoing ECT found in a previous study. There were no cases of clinically significant rise or fall in blood glucose. We provide recommendations for management of diabetics during ECT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801828     DOI: 10.1097/00124509-200606000-00009

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  3 in total

1.  Effect of electroconvulsive shock on mitochondrial respiratory chain in rat brain.

Authors:  Márcio Búrigo; Clarissa A Roza; Cintia Bassani; Diego A Fagundes; Gislaine T Rezin; Gustavo Feier; Felipe Dal-Pizzol; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2006-10-25       Impact factor: 3.996

Review 2.  Insulin and takotsubo syndrome: plausible pathophysiologic, diagnostic, prognostic, and therapeutic roles.

Authors:  John E Madias
Journal:  Acta Diabetol       Date:  2021-04-02       Impact factor: 4.280

3.  Electroconvulsive therapy and adiposity-related parameters in treatment-resistant depressed patients.

Authors:  Hannah Benedictine Maier; Christoph Pollak; Nicole Moschny; Sermin Toto; Colin Schlatt; Christian K Eberlein; Wolfgang Sperling; Johannes Kornhuber; Kai G Kahl; Stefan Bleich; Alexandra Neyazi; Helge Frieling
Journal:  J Neural Transm (Vienna)       Date:  2022-02-25       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.